Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,986,116
+$1,740,815 QoQ
Shares Held
47,632
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#831
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $42,723,383 across 10 Drug Manufacturers - General names. ABBV ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
47,632 | $11,986,116 | |
| 2 | JNJ |
Johnson & Johnson
|
36,037 | $9,152,316 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,713 | $7,544,620 | |
| 4 | LLY |
ELI LILLY & Co
|
5,751 | $6,897,922 | |
| 5 | AMGN |
Amgen Inc
|
10,322 | $3,737,802 | |
| 6 | NVO |
Novo Nordisk A S
|
22,899 | $1,097,778 | |
| 7 | BIIB |
Biogen Inc.
|
3,987 | $861,431 | |
| 8 | NVS |
Novartis AG
|
4,542 | $711,822 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,986,116 | 47,632 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,245,301 | 47,107 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $10,726,920 | 46,947 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,895,788 | 42,739 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $7,777,106 | 41,898 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $7,963,436 | 38,008 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $6,742,826 | 37,945 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,582,837 | 38,398 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,586,024 | 38,398 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,056,010 | 38,748 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,997,029 | 38,698 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,037,780 | 33,797 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,593,888 | 34,097 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,346,385 | 33,547 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,421,530 | 33,547 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,488,921 | 33,447 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,149,545 | 33,622 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,405,882 | 33,347 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,498,935 | 33,227 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,525,407 | 32,682 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,652,014 | 32,422 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,472,996 | 32,092 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,425,585 | 31,970 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,778,354 | 31,720 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,115,644 | 31,734 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $2,274,804 | 29,857 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||